A Randomized, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Metformin Compared With Metformin Plus Sitagliptin, Metformin Plus Glimepiride, and Metformin Plus Placebo in Subjects With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Metformin Compared With Metformin Plus Sitagliptin, Metformin Plus Glimepiride, and Metformin Plus Placebo in Subjects With Type 2 Diabetes Mellitus
The purpose of this study is to determine if albiglutide is safe and effective in the treatment of type 2 diabetes.
Inclusion Criteria:
Exclusion Criteria:
Satna Monica, California 90404, United States
Downington, Pennsylvania 19335, United States
Landsdale, Pennsylvania 19446, United States
Sugarland, Texas 77479, United States
Virgina Beach, Virginia 23455, United States
Alabaster, 35007, Albania
Kwun Tong, Kowloon, Hong Kong
Callao, Lima Callao 2, Peru
Taytay Rizal, 1920, Philippines